Moderna tests vaccine for 4 flu strains


Moderna has launched a Phase 2/3 trial for an mRNA-based vaccine designed to produce antibodies against four strains of flu. The company's goal is to develop a vaccine that works against seasonal flu, respiratory syncytial virus and COVID-19.

Full story:

AIChE SmartBrief

Chemical engineering news

Designed specifically for chemical engineers, AIChE SmartBrief is a FREE weekly e-mail newsletter. It helps chemical engineers stay informed on the business and technology developments affecting our profession.